Health economics of depression
著者
書誌事項
Health economics of depression
（Perspectives in psychiatry, v. 4）
Wiley, c1993
大学図書館所蔵 件 / 全7件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Perspectives in Psychiatry Volume 4 Health Economics of Depression Edited by B. Jonsson Stockholm School of Economics, Sweden and J. Rosenbaum Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA Major depressive illness is associated with significant morbidity and imposes large social and financial burdens on the individual and society. In view of the demands made on finite health care resources, clinical psychiatry must increasingly focus on the cost-effectiveness of treatment options as well as their safety, efficacy and impact on quality of life. In this book a multidisciplinary team of health economists and psychiatrists explores the concept of mental health economics and highlights its importance to the practising psychiatrist. Attention is drawn to the cost of mental illness to the community, the economic consequences of treatment failure and the analysis of cost-effectiveness of pharmacological treatment of depression. Perspectives in Psychiatry Series Advisors: O. Benkert (Germany) G. B. Cassano (Italy) J. P. Feighner (USA) D. G. Grahame-Smith (UK) J. J. Lopez-lbor (Spain) J. Mendlewicz (Belgium) S. A. Montgomery (UK) F.
Rouillon (France) Volume 1: Selective Serotonin Re-uptake Inhibitors J. P. Feighner and W. F. Boyer ISBN 0 471 92890 9 1991 168pp Volume 2: Diagnosis of Depression Edited by J. P. Feighner and W. F. Boyer ISBN 0 471 92891 7 1991 202pp Volume 3: Long-term Treatment of Depression Edited by S. A. Montgomery and F. Rouillon ISBN 0 471 92892 5 1992 275pp
目次
Health Economics in the 1990s (M. Buxton). Economics of Mental Illness: Costs, Benefits and Incentives (B. Weisbrod). Economic Studies of the Treatment of Depressive Illness (B. J?nsson & P. Bebbington). The Cost of Treatment Failure (J. McCombs & M. Nichol). The Financial Implications of Starting Treatment with a Selective Serotonin Reuptake Inhibitor or Tricyclic Antidepressant in Drug-Naive Depressed Patients (W. Boyer & J. Feighner). Outcomes, Costs and Design of Health Insurance for Depression (T. McGuire). The Economic Impact of an Educational Program on Diagnosis and Treatment of Depression in Sweden (J. W?linder, et al.). The Challenge of Measuring Quality of Life in Psychiatric Patients (P. Bech, et al.). Social Aspects of Treating Depression (D. Currie, et al.). Clinical Choices, Cost-Effectiveness and Antidepressant Treatments (J. Rosenbaum). Index.
「Nielsen BookData」 より